Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hepatitis B Immune Globulin for Prevention of Maternal-to-Infant Transmission
NCT00000580Phase 3Completed
- Sponsor
- National Heart, Lung, and Blood Institute
- Start
- Nov 1975
- Modality
- Antibody Conjugates, Recombinant Proteins and Enzymes, Engineered Antibody Formats
01
Overview
A Phase 3 trial of hepatitis B immune globulin in hepatitis B (HBV), sponsored by National Heart, Lung, and Blood Institute. Started Nov 1975; status: completed.
02
Drugs
hepatitis B immune globulin
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on NCT00000580.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00000580.